Teclistamab, a B-cell maturation antigen (BCMA) x CD3 bispecific antibody, in patients with relapsed/refractory multiple myeloma (RRMM): Correlative analyses from MajesTEC-1 Meeting Abstract
| Authors: | Cortes-Selva, D.; Casneuf, T.; Vishwamitra, D.; Stein, S.; Perova, T.; Skerget, S.; Ramos, E.; van Steenbergen, L.; De Maeyer, D.; Boominathan, R.; Lau, O.; Davis, C.; Banerjee, A.; Stephenson, T.; Uhlar, C. M.; Kobos, R.; Goldberg, J. D.; Pei, L.; Trancucci, D.; Girgis, S.; Lin, S. X. W.; Wu, L. S.; Moreau, P.; Usmani, S.; Bahlis, N. J.; Van De Donk, N. W. C. J.; Verona, R. |
| Abstract Title: | Teclistamab, a B-cell maturation antigen (BCMA) x CD3 bispecific antibody, in patients with relapsed/refractory multiple myeloma (RRMM): Correlative analyses from MajesTEC-1 |
| Meeting Title: | 64th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 140 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2022 Dec 10-13 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2022-11-15 |
| Start Page: | 241 |
| End Page: | 243 |
| Language: | English |
| ACCESSION: | WOS:000893223200098 |
| DOI: | 10.1182/blood-2022-162709 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
